Microchip Technology Projects Year-Over-Year Decline in Q3 Earnings and Revenue
Microchip Technology Incorporated (NASDAQ:MCHP) is set to release its quarterly earnings on November 6, 2025, with analysts projecting a year-over-year decline in key financial metrics. The Wall Street consensus for earnings per share (EPS) is $0.33, which would mark a 28.3% decrease from the same period last year. Revenue is forecast to be approximately $1.13 billion, a 2.7% year-over-year decline.
The company's own guidance anticipates an EPS range between $0.34 and $0.37. For net sales, Microchip has provided a range of $1.11 billion to $1.15 billion. Despite the projected annual decline, this forecast suggests a sequential growth of 5.1%. The company attributes this expected growth to improving inventory levels, increased direct shipments, and strong design wins in the industrial, aerospace, and AI sectors.
Several financial metrics provide additional context on the company's market position. The price-to-sales ratio is approximately 7.75, and the enterprise value to sales ratio stands at about 8.91. The company maintains a moderate debt-to-equity ratio of about 0.80. Furthermore, its current ratio of approximately 2.31 indicates a strong capacity to meet short-term obligations.
For further information, explore the company's history and ownership, its mission and vision, its financial health, and its investor profile.
Microchip Technology Incorporated (MCHP) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.